📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study. (2023)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41591-022-02121-6

PubMed Identifier: 36477734

Publication URI: http://europepmc.org/abstract/MED/36477734

Type: Journal Article/Review

Volume: 29

Parent Publication: Nature medicine

Issue: 2

ISSN: 1078-8956